Jee-Hong Kim, MD
Otolaryngology · Walnut Creek, CANPI 1629423140
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $98,088 of the $130,768 with a category attached, or 75.0%. Regeneron Healthcare Solutions, Inc. accounts for 60.5% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $79,147, more than ten times the $123 reported in 2019. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 290 payments — averaging $450.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$79K
- GSK$32K
- Sanofi$10K
- Regeneron$3K
- Inspire Medical Systems, Inc.$2K
- Medtronic$1K
- plus $3K from 13 others
What the payments were for
- Consulting fees$9,7507%
- Speaking & faculty fees$98,08875%
- Travel & lodging$12,72110%
- Food & beverage$10,0888%
- Education$1220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 101 | $79,177 |
| GSK | 58 | $31,958 |
| Sanofi | 11 | $10,378 |
| Regeneron | 4 | $3,215 |
| Inspire Medical Systems, Inc. | 35 | $1,567 |
| Medtronic | 14 | $1,127 |
| Aerin Medical Inc. | 10 | $1,070 |
| Optinose US, Inc. | 18 | $668 |
| Stryker | 5 | $603 |
| Smith+Nephew | 19 | $522 |
| Olympus America Inc. | 1 | $127 |
| United Therapeutics Corporation | 3 | $81 |
| AstraZeneca | 2 | $64 |
| Amgen | 2 | $56 |
| Lilly USA, LLC | 3 | $55 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $38 |
| Merck | 1 | $23 |
| KARL Storz Endoscopy-america | 1 | $21 |
| Philips North America LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$100,102
- NUCALA$30,185
- Inspire$835
- VIVAER STYLUS$708
- Xhance$340
- SCOPIS ENT$269
- STEALTHSTATION S8 PLATFORM$264
- SONOPET IQ$161
- NA$161
- ADHERUS AUTOSPRAY DURAL SEALANT$161
- CORE$161
- AQUAMANTYS$136
- XPRESS ENT DILATION SYSTEM$136
- RHINO-LARYNGO VIDEOSCOPE$127
- SINUVA$126
- FUSION$122
- PTEYE PARATHYROID DETECTION SYSTEM$120
How this compares
$130,768 in reported general payments places this provider in the 95th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $44,905 |
| Azelastine Hcl | 35 | $917 |
| Ipratropium Bromide | 52 | $770 |
| Doxycycline Hyclate | 15 | $162 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Walnut Creek
- Karen FongWalnut Creek$21K
- Brian WeeksSan Diego$924K
- Randall OwRoseville$613K
- Amir MoradiVista$389K
- Keith BlackwellLos Angeles$349K
- Kalpna DurairajSun Valley$348K
- Todd MillerNewport Beach$259K
- Jeffrey SuhLos Angeles$223K
- Dennis TangLos Angeles$209K
- Jeffrey FeinfieldThousand Oaks$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.